Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0RX7Z
|
||||
Former ID |
DNC014595
|
||||
Drug Name |
DEOXYCYTIDINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] | Approved | [1], [2] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C9H13N3O4
|
||||
Canonical SMILES |
C1C(C(OC1N2C=CC(=NC2=O)N)CO)O
|
||||
InChI |
1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1
|
||||
InChIKey |
CKTSBUTUHBMZGZ-SHYZEUOFSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Thymidine kinase | Target Info | Inhibitor | [3] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000912) | ||||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
REF 3 | J Med Chem. 1982 Jun;25(6):644-9.Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.